These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25037807)

  • 1. Ophthalmic cyclosporine for the treatment of psoriatic conjunctivitis.
    Habeshian KA; Levitt JO
    J Am Acad Dermatol; 2014 Aug; 71(2):e43-4. PubMed ID: 25037807
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary syphilis on a psoriatic patient under cyclosporine: a challenging case.
    Pinto-Almeida T; Rosmaninho A; Sanches M; Alves R; Selores M
    Int J Dermatol; 2014 Jan; 53(1):e35-8. PubMed ID: 23330914
    [No Abstract]   [Full Text] [Related]  

  • 3. Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia.
    Fozza C; Dore F; Bonfigli S; Podda L; Longinotti M
    Eur J Dermatol; 2005; 15(4):271-3. PubMed ID: 16048757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance treatment of psoriasis with cyclosporine A: comparison between continuous and weekend therapy.
    Fernandes IC; Torres T; Selores M
    J Am Acad Dermatol; 2013 Feb; 68(2):341-2. PubMed ID: 23317974
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of ligneous conjunctivitis with topical cyclosporine and heparin.
    Azad N; Zafar S; Khan A
    J AAPOS; 2009 Oct; 13(5):519-20. PubMed ID: 19840736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cyclosporine A.
    Yamamoto T; Kimura K; Katayama I; Nishioka K
    J Dermatol; 1995 Jul; 22(7):512-4. PubMed ID: 7560444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of topical cyclosporin for conjunctival manifestations of actinic prurigo.
    McCoombes JA; Hirst LW; Green WR
    Am J Ophthalmol; 2000 Dec; 130(6):830-1. PubMed ID: 11124306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.
    Borghi A; Corazza M; Mantovani L; Bertoldi AM; Giari S; Virgili A
    Int J Dermatol; 2012 Dec; 51(12):1512-6. PubMed ID: 23171021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of quality of life and clinical usefulness of cyclosporin administration in patients with nail psoriasis.
    Abe M; Syuto T; Yokoyama Y; Ishikawa O
    J Dermatol; 2011 Sep; 38(9):916-8. PubMed ID: 21352333
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical cyclosporin A in severe allergic conjunctivitis.
    Bellini LP; Bulla MC; Brum GS
    Cornea; 2008 Jun; 27(5):625; author reply 625. PubMed ID: 18520520
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical ciclosporin 1 mg/ml for chronic ocular surface inflammation in children.
    Parvizi S; Muthusamy K; Hingorani M; Dahlmann-Noor A
    Eye (Lond); 2018 Jul; 32(7):1290-1291. PubMed ID: 29472696
    [No Abstract]   [Full Text] [Related]  

  • 12. Ophthalmic Considerations in Stevens-Johnson Syndrome.
    Thomas L; Weng M; Schulze R; Bromley J; Thacker S
    J Pediatr; 2016 Aug; 175():235. PubMed ID: 27318376
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine A microemulsion in dermatological practice: is oral solution better tolerated than soft gelatin capsules?
    Garcovich S; Garcovich C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2015 Aug; 150(4):473-4. PubMed ID: 26224233
    [No Abstract]   [Full Text] [Related]  

  • 14. Images in clinical medicine. Giant papillae in vernal keratoconjunctivitis.
    Ram J; Agarwal A
    N Engl J Med; 2014 Apr; 370(17):1636. PubMed ID: 24758619
    [No Abstract]   [Full Text] [Related]  

  • 15. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
    Yamauchi PS; Lowe NJ
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine as maintenance therapy in patients with severe psoriasis.
    Mrowietz U
    J Am Acad Dermatol; 2013 Aug; 69(2):308-9. PubMed ID: 23866863
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
    Yoon HS; Youn JI
    J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
    Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
    J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal time for therapeutic drug monitoring of cyclosporine microemulsion in patients with psoriasis.
    Umezawa Y; Ozawa A
    Int J Dermatol; 2007 Jul; 46(7):763-6. PubMed ID: 17614813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preprandial vs. postprandial pharmacokinetics of cyclosporine in patients with psoriasis.
    Umezawa Y; Mabuchi T; Ozawa A
    Int J Dermatol; 2007 Aug; 46(8):880-2. PubMed ID: 17651179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.